Jones M M
Department of Chemistry, Vanderbilt University, Nashville, TN 37235.
Crit Rev Toxicol. 1991;21(3):209-33. doi: 10.3109/10408449109089880.
An examination of the studies on therapeutic chelating agents that have been carried out during the last decade reveals that extensive efforts have been made to develop compounds superior to those previously available for the treatment of acute and chronic intoxication by many metals. These metals include primarily iron, plutonium, cadmium, lead, and arsenic, but also many other elements for which acute and chronic intoxication is less common. These studies have revealed the importance of several additional factors of importance in the design of such compounds and have led to many new compounds of considerable clinical promise. An additional development has been the introduction of previously developed chelating agents for use with certain metals on a broader scale.
对过去十年间开展的关于治疗性螯合剂的研究进行审视后发现,人们已付出大量努力来研发比此前用于治疗多种金属所致急慢性中毒的化合物更优的化合物。这些金属主要包括铁、钚、镉、铅和砷,但也包括许多其他急慢性中毒不太常见的元素。这些研究揭示了此类化合物设计中其他几个重要因素的重要性,并催生了许多具有可观临床前景的新化合物。另一项进展是将先前研发的螯合剂更广泛地用于某些金属。